Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2000
03/22/2000EP0986391A1 Oxyalkylene phosphate compounds and uses thereof
03/22/2000EP0986389A1 Novel process
03/22/2000EP0986386A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/22/2000EP0986371A1 Liquid antimicrobial cleansing compositions
03/22/2000EP0986370A1 Cosmetic product containing plant extracts
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1248274A Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof
03/22/2000CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker
03/22/2000CN1248158A Method for improving health of hair and scalp
03/22/2000CN1247754A Medicine ointment for skin allergy caused by violet ray and cosmetics, dermatitis and other skin diseases
03/22/2000CN1247735A Face skin-care oil
03/22/2000CN1050519C Chinese medicine granule for treatment of acne
03/21/2000US6040347 Treatment of seborrhoea/cutaneous disorders with octoxyglycerol
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
03/21/2000US6040302 1,4-disubstituted piperazines
03/21/2000US6039963 Ceramide compounds, process for their preparation and use
03/21/2000CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors
03/17/2000CA2281999A1 Anti-wrinkle composition containing a combination of tightening polymers of synthetic and/or natural origin and of dendritic polyesters
03/16/2000WO2000014236A2 Grf analogs with increased biological potency
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000013710A2 Hydrogel compositions for the controlled release administration of growth factors
03/16/2000WO2000013693A2 Antipollution plant complex, production process and utilization of said complex in the preparation of pharmaceutical and/or cosmetic compositions
03/16/2000WO2000013660A1 Lipid extract of the skeletonema algae
03/16/2000WO2000013654A2 A carotenoid composition containing phytoene and phytofluene
03/16/2000WO2000013653A1 Organosilicone compositions for personal care
03/16/2000WO2000013649A2 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis
03/16/2000WO2000006694A3 Compound and method for the prevention and/or the treatment of allergy
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999050403A9 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
03/16/2000DE19841698A1 Composition for accelerating healing of tissue damage in cartilage or wounds, comprises thrombocyte growth factor, fibrin or fibrinogen and polymer
03/16/2000CA2343637A1 Organosilicone compositions for personal care
03/16/2000CA2342882A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000CA2342855A1 Novel pyranoses
03/16/2000CA2342070A1 Grf analogs with increased biological potency
03/15/2000EP0985416A2 Process and device for making an extract of biological material
03/15/2000EP0985015A1 Disinfecting compositions and processes for disinfecting surfaces
03/15/2000EP0984981A1 Anti-inflammatory tyrosine derivatives
03/15/2000EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
03/15/2000EP0984963A1 Novel compounds
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS
03/15/2000EP0984940A1 Cyanoamidines as cell proliferation inhibitors
03/15/2000EP0984939A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984938A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984937A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984936A1 Cyanoguanidines as cell proliferation inhibitors
03/15/2000EP0984771A1 Stabilized gas-supersaturated emulsions and suspensions
03/15/2000EP0984769A1 Mild, antimicrobial wipes
03/15/2000EP0984692A1 Novel angiogenesis inhibitors
03/15/2000CN1247531A Arylsulfonyl hydroxamic acid derivatives
03/15/2000CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor
03/15/2000CN1247077A Medical oil for treating burn and scald and its preparing process
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000US6037488 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
03/14/2000US6037481 Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment
03/14/2000US6037377 Antiinflammatory agents and antiallergens
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/14/2000US6036956 Method and dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012726A2 Rationally designed heparinases derived from heparinase i and ii
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012501A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000WO2000012499A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012489A1 1, 2, 4-triazole-3-thione compounds
03/09/2000WO2000012485A1 Pyrimidine compounds
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012467A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
03/09/2000WO2000012175A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
03/09/2000WO2000012170A1 Gelatinous body protection article having a therapeutic additive
03/09/2000WO2000012119A2 PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012108A1 Dry extract of henna, method for producing said extract and use of the same
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
03/09/2000WO2000012089A1 Novel angiogenesis inhibitors
03/09/2000WO2000012085A1 Ascorbate-isoquercetin compositions
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012049A2 A method for the treatment of staphylococcal disease
03/09/2000WO1999053949A3 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
03/09/2000DE19838918A1 Composition for the topical treatment of skin disorders, especially eczema, comprises green tea or derivative, salicylic acid or acetylsalicylic acid, as well as vitamin C
03/09/2000DE19838809A1 Trockenextrakt aus der Hennapflanze, Verfahren zu dessen Herstellung und dessen Verwendung Dry extract of the henna plant, process for its preparation and its use
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342245A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
1 ... 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 ... 1065